Correlation Between Agenus and CEL SCI
Can any of the company-specific risk be diversified away by investing in both Agenus and CEL SCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agenus and CEL SCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agenus Inc and CEL SCI Corp, you can compare the effects of market volatilities on Agenus and CEL SCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agenus with a short position of CEL SCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agenus and CEL SCI.
Diversification Opportunities for Agenus and CEL SCI
Very poor diversification
The 3 months correlation between Agenus and CEL is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Agenus Inc and CEL SCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEL SCI Corp and Agenus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agenus Inc are associated (or correlated) with CEL SCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEL SCI Corp has no effect on the direction of Agenus i.e., Agenus and CEL SCI go up and down completely randomly.
Pair Corralation between Agenus and CEL SCI
Given the investment horizon of 90 days Agenus Inc is expected to under-perform the CEL SCI. In addition to that, Agenus is 1.09 times more volatile than CEL SCI Corp. It trades about -0.06 of its total potential returns per unit of risk. CEL SCI Corp is currently generating about -0.03 per unit of volatility. If you would invest 242.00 in CEL SCI Corp on September 30, 2024 and sell it today you would lose (182.00) from holding CEL SCI Corp or give up 75.21% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Agenus Inc vs. CEL SCI Corp
Performance |
Timeline |
Agenus Inc |
CEL SCI Corp |
Agenus and CEL SCI Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Agenus and CEL SCI
The main advantage of trading using opposite Agenus and CEL SCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agenus position performs unexpectedly, CEL SCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will offset losses from the drop in CEL SCI's long position.Agenus vs. Marker Therapeutics | Agenus vs. Edgewise Therapeutics | Agenus vs. Adaptimmune Therapeutics Plc | Agenus vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Valuation Check real value of public entities based on technical and fundamental data |